Randomized trial · 2018

Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial.

Devinsky O, Nabbout R, Miller I, Laux L, Zolnowska M, Wright S, Roberts C.

Study design
Randomized trial
Population / model
Human
Published
2018-12-23
Journal
Epilepsia
Sample mentioned
278 patients — Number stated in the abstract; not independently verified.

From the author abstract

“By November 2016, a total of 278 patients had completed the original randomized trials, and 264 (95%) enrolled in this open-label extension. …”

A short attributed excerpt. Read the full abstract and original paper for methods, results and limitations.

Outcome summaries · provisional

Selected source sets; evidence confidence remains ungraded.

CBD and convulsive seizures in Dravet syndrome →

Citation and indexing details

PMID 30582156 · PMC7379690

Publication types: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Topic tags: Epilepsy

Metadata checked 2026-11-04. Study design and model tags follow indexing and explicit abstract terms. Citation counts are not evidence of benefit. An available full text does not by itself permit image reuse.